Chargement en cours...
Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC
BACKGROUND: Renal cell carcinoma (RCC) is notorious for its resistance towards chemotherapy and radiation therapy in general. Combination therapy is often helpful in alleviating the resistance mechanisms by targeting multiple signaling pathways but is usually more toxic than monotherapy. Co-encapsul...
Enregistré dans:
| Publié dans: | Int J Nanomedicine |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6636461/ https://ncbi.nlm.nih.gov/pubmed/31371950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S204221 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|